Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01)
The summary for the Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01): The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research focused on the discovery of mechanisms that mediate effective antigen-specific memory T cell responses in the female reproductive tract (FRT). The ultimate goal is to develop the knowledge base needed to develop future vaccines that elicit effective and durable T cell responses against infection by HIV and other viral pathogens in the FRT. This FOA is intended to support innovative basic research efforts and is not intended to support the preclinical or clinical development of vaccine candidates or adjuvants. A similar concept was previously released as PA-12-104, and applicants are urged to read this FOA carefully, since there are differences that could alter responsiveness. Investigators with the appropriate expertise, but not currently in the HIV field are encouraged to apply.
Federal Grant Title: | Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AI-12-054 |
Type of Funding: | Grant |
CFDA Numbers: | 93.855 |
CFDA Descriptions: | Allergy, Immunology and Transplantation Research |
Current Application Deadline: | Jul 24, 2013 |
Original Application Deadline: | Jul 24, 2013 |
Posted Date: | Mar 07, 2013 |
Creation Date: | Mar 07, 2013 |
Archive Date: | Aug 24, 2013 |
Total Program Funding: | $2,000,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
- • Molecular Mechanisms of Combination Adjuvants (MMCA) (R01 Clinical Trial Not Allowed)
- • Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
- • Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 C...
- • Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 C...
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Scie...
- • New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not All...
- • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
- • Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- • Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)